123I-ACD-101

N/A

Report date: 2026/02/27 20:01:47

NME

Base Information

Drug Name123I-ACD-101

Drug Alias Name123I-4-Iodophenylalanine123I-ACD-101123I-TLX101123I-IPA

ClassificationRadiation-emitting products > Nuclides > Iodine > 123IRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionL-type amino acid transporter 1 inhibitors

TargetsL-type amino acid transporter 1

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTherapeia GmbH & Co KG

China Registration ClassN/A

Develop Information

Active CompaniesTherapeia GmbH & Co KG

Inactive CompaniesN/A

Active IndicationsGlioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A